SELLAS Life Sciences Group (SLS) Change in Accured Expenses: 2011-2024
Historic Change in Accured Expenses for SELLAS Life Sciences Group (SLS) over the last 7 years, with Sep 2024 value amounting to $307,000.
- SELLAS Life Sciences Group's Change in Accured Expenses fell 55.44% to $307,000 in Q3 2024 from the same period last year, while for Sep 2024 it was -$1.4 million, marking a year-over-year decrease of 157.40%. This contributed to the annual value of -$2.2 million for FY2024, which is 250.72% down from last year.
- SELLAS Life Sciences Group's Change in Accured Expenses amounted to $307,000 in Q3 2024, which was up 121.54% from -$1.4 million recorded in Q2 2024.
- Over the past 5 years, SELLAS Life Sciences Group's Change in Accured Expenses peaked at $1.7 million during Q4 2022, and registered a low of -$1.4 million during Q2 2024.
- In the last 3 years, SELLAS Life Sciences Group's Change in Accured Expenses had a median value of $215,000 in 2022 and averaged $266,818.
- Per our database at Business Quant, SELLAS Life Sciences Group's Change in Accured Expenses skyrocketed by 2,713.11% in 2022 and then crashed by 631.63% in 2024.
- Quarterly analysis of 5 years shows SELLAS Life Sciences Group's Change in Accured Expenses stood at -$391,000 in 2020, then soared by 115.60% to $61,000 in 2021, then spiked by 2,713.11% to $1.7 million in 2022, then crashed by 53.03% to $806,000 in 2023, then crashed by 55.44% to $307,000 in 2024.
- Its Change in Accured Expenses stands at $307,000 for Q3 2024, versus -$1.4 million for Q2 2024 and -$1.0 million for Q1 2024.